![George Poste](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
George Poste
Directeur/Membre du Conseil chez
CARIS LIFE SCIENCES, INC.
Fortune : 15 M $ au 31/05/2026
Profil
George H.
Poste is Chief Executive Officer at Health Technology Networks, Inc. since 2000.
He is Vice Chairman at Caris Life Sciences, Inc. since 2008.
He serves as Independent Director at Exelixis, Inc. since 2004.
He is Director at Caris Holdings Ltd. and Medisix Therapeutics, Inc. He is a Member of the Council on Foreign Relations, Inc. He is Chief Scientist at Complex Adaptive Systems Initiative since 2009.
He is a Member of The Hoover Institution.
Formerly, Dr. Poste was Non-Executive Chairman at Orchid Cellmark, Inc. from 2000 to 2009, Non-Executive Chairman at diaDexus, Inc. from 1997 to 2004, and Non-Executive Chairman at SGX Pharmaceuticals, Inc. from 2000 to 2004.
He was Director at Caremark Rx, Inc., INanoBio, Inc., Calviri, Inc., AdvancePCS from 2002 to 2005, Illumina, Inc. from 2000 to 2003, Structural Genomix, Inc. from 2000 to 2003, and Monsanto Co. from 2012 to 2018.
He was Director & Professor at Arizona State University from 2003 to 2009 and Director at Biodesign Institute from 2003 to 2009.
He was Chief Science & Technology Officer at GSK Plc and GlaxoSmithKline LLC from 1992 to 1999.
He was Senior Technical Advisor at Caris Ltd. He was Member-Defense Science Board at US Department of Defense from 2001 to 2010.
He was Member of Bipartisan Commission On Biodefense from 2000 to 2009.
Education includes a doctorate from the University of Bristol conferred in 1969 and another doctorate from the University of Bristol conferred in 1987.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/05/2026 | 529 431 ( 0,19 % ) | 9 M $ | 31/05/2026 | |
EXELIXIS, INC. 0,05 % | 27/05/2026 | 127 199 ( 0,05 % ) | 6 M $ | 31/05/2026 |
Postes actifs de George Poste
| Sociétés | Poste | Début |
|---|---|---|
| EXELIXIS, INC. | Directeur/Membre du Conseil | 01/08/2004 |
| CARIS LIFE SCIENCES, INC. | Directeur/Membre du Conseil | 01/01/2008 |
Medisix Therapeutics, Inc.
 Medisix Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel cellular therapies | Directeur/Membre du Conseil | - |
Council on Foreign Relations, Inc.
 Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | - |
Complex Adaptive Systems Initiative | Directeur Technique/Scientifique/R&D | 01/02/2009 |
Caris Holdings Ltd. | Directeur/Membre du Conseil | 14/12/2010 |
Health Technology Networks, Inc.
 Health Technology Networks, Inc. Packaged SoftwareTechnology Services Develops application of genomic technologies and computing in healthcare | Directeur Général | 01/01/2000 |
The Hoover Institution
 The Hoover Institution Miscellaneous Commercial ServicesCommercial Services Operates as research center dedicated to supporting knowledge in economics, politics, history and public policy | Corporate Officer/Principal | - |
Anciens postes connus de George Poste
| Sociétés | Poste | Fin |
|---|---|---|
| MONSANTO | Directeur/Membre du Conseil | 07/06/2018 |
| ░░ ░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de George Poste
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
26
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 26 |
|---|---|
AdvancePCS
 AdvancePCS Medical/Nursing ServicesHealth Services Provides health improvement services | Health Services |
Caremark Rx, Inc.
 Caremark Rx, Inc. Medical/Nursing ServicesHealth Services Provides pharmaceutical and prescription benefit program services | Health Services |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Orchid Cellmark, Inc.
 Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Provides DNA testing services | Commercial Services |
Illumina, Inc.
 Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
Monsanto Co.
 Monsanto Co. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company controlling insects and weeds & manufactures seeds and genomics | Commercial Services |
diaDexus, Inc. /Old/
 diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology Develops and markets diagnostic products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs and other pharmaceutical products | Health Technology |
Arizona State University
 Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Caris Ltd.
 Caris Ltd. Investment ManagersFinance Caris invests in companies located in the United States. The firm focuses on healthcare, energy, retail and financial services sectors. It provides financing for acquisitions and recapitalization transactions with an investment size of USD 20 - 100 million. It also acquires majority stakes. | Finance |
Council on Foreign Relations, Inc.
Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
US Department of Defense (District of Columbia)
 US Department of Defense (District of Columbia) SovereignGovernment Operates and maintains defense departments | Government |
Health Technology Networks, Inc.
Health Technology Networks, Inc. Packaged SoftwareTechnology Services Develops application of genomic technologies and computing in healthcare | Technology Services |
The Hoover Institution
The Hoover Institution Miscellaneous Commercial ServicesCommercial Services Operates as research center dedicated to supporting knowledge in economics, politics, history and public policy | Commercial Services |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Caris Life Sciences, LLC
 Caris Life Sciences, LLC BiotechnologyHealth Technology Operates as an AI-powered biotech company that provides molecular profiling services to develop oncology pharmaceuticals with proprietary platform | Health Technology |
Caris Holdings Ltd. | |
Complex Adaptive Systems Initiative | |
Structural Genomix, Inc. | |
Biodesign Institute
 Biodesign Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
INanoBio, Inc.
 INanoBio, Inc. SemiconductorsElectronic Technology Develops nano sensor devices for sensing of chemical and biological species with very low false positives and false negatives, for applications in health care diagnostics, industrial leak detection systems and security | Electronic Technology |
Calviri, Inc.
 Calviri, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops vaccines to eliminate cancer | Health Technology |
Medisix Therapeutics, Inc.
Medisix Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel cellular therapies | Commercial Services |
Bipartisan Commission On Biodefense |
